Publicaties van Durk Wiersma

Swildens WE, Visser E, Bahler M, Bruggeman R, Delespaul P, Gaag van der M, Haan de L, Keet R, Nijssen Y, Os van J, Pijnenborg GM, Slooff C, Vos de A, Weeghel van J, Wunderink L, Mulder CL, Wiersma D. (2018). Functional recovery of individuals with serious mental illnesses: Development and testing of a new short instrument for routine outcome monitoring. Psychiatric rehabilitation journal, 41: 341-350. [Volledige tekst]

Scheffers M, Busschbach van JT, Bosscher RJ, Aerts LC, Wiersma D, Schoevers RA. (2017). Body image in patients with mental disorders: Characteristics, associations with diagnosis and treatment outcome. Comprehensive psychiatry, 74: 53-60. [Volledige tekst]

Scheffers M, Duijn van MAJ, Bosscher RJ, Wiersma D, Schoevers RA, Busschbach van JT. (2017). Psychometric properties of the Dresden Body Image Questionnaire: A multiple-group confirmatory factor analysis across sex and age in a Dutch non-clinical sample. PloS one, 12: e0181908. [Volledige tekst]

Busschbach van JT, Swildens W, Michon H, Kroon H, Koeter M, Wiersma D, Os van J. (2016). Working effectively towards rehabilitation goals: long-term outcome of a randomised controlled trial of the Boston psychiatric rehabilitation approach. Tijdschrift voor Psychiatrie, 58: 179-189. [Volledige tekst]

Heering HD, Goedhart S, Bruggeman R, Cahn W, Haan de L, Kahn RS, Meijer CJ, Myin-Germeys I, Os van J, Wiersma D. (2016). Disturbed Experience of Self: Psychometric Analysis of the Self-Experience Lifetime Frequency Scale (SELF). Psychopathology, 49: 69-76. [Volledige tekst]

Horwitz EH, Schoevers RA, Ketelaars CEJ, Kan CC, Lammeren van AMDN, Meesters Y, Spek AA, Wouters S, Teunisse JP, Cuppen L, Bartels AAJ, Schuringa E, Moorlag H, Raven D, Wiersma D, Minderaa RB, Hartman CA. (2016). Clinical assessment of ASD in adults using self- and other-report: Psychometric properties and valdity of the Adult Social Behavior Questionnaire (ASBQ). Research in Autism Spectrum Disorders, 24: 17-28. [Volledige tekst]

Killaspy H, Cardoso G, White S, Wright C, Caldas de Almeida JM, Turton P, Taylor TL, Schutzwohl M, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisova L, Onchev G, Alexiev S, Mezzina R, Ridente P, Wiersma D, Visser E, Kiejna A, Adamowski T, Ploumpidis D, Gonidakis F, King M. (2016). Quality of care and its determinants in longer term mental health facilities across Europe; a cross-sectional analysis. BMC Psychiatry, 16: 31-016-0737-5. [Volledige tekst]

Lako IM, Taxis K, Heuvel van den ER, Leenaars CH, Burger H, Wiersma D, Slooff CJ, Knegtering H, Bruggeman R. (2016). Altered emotional experiences attributed to antipsychotic medications – A potential link with estimated dopamine D receptor occupancy. Psychiatry Research, 236: 9-14. [Volledige tekst]

Medema S, Mocking RJ, Koeter MW, Vaz FM, Meijer C, Haan de L, Beveren van NJ, GROUP, Genetic Risk and Outcome of Psychosis investigators:, Kahn R, Haan de L, Os van J, Wiersma D, Bruggeman R, Cahn W, Meijer C, Myin-Germeys I. (2016). Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls. Schizophrenia bulletin, 42: 358-368. [Volledige tekst]

Peeters SC, Gronenschild EH, Amelsvoort van T, Os van J, Marcelis M, Genetic Risk and Outcome of Psychosis (G.R.O.U.P.), Kahn R, Wiersma D, Bruggeman R, Cahn W, Haan de L, Meijer C, Myin-Germeys I. (2016). Reduced specialized processing in psychotic disorder: a graph theoretical analysis of cerebral functional connectivity. Brain and Behavior, 6: e00508. [Volledige tekst]

Boer de M, Swart M, Wiersma D, Schoevers R, Knegtering R. (2015). Seksuele bijwerkingen bij gebruik van depot antipsychotica. GGzet Wetenschappelijk, 19: 19-24.

Boer de MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. (2015). The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings. Schizophrenia Bulletin, 41: 674-686. [Volledige tekst]

Brink van den RH, Troquete NA, Beintema H, Mulder T, Os van TW, Schoevers RA, Wiersma D. (2015). Risk assessment by client and case manager for shared decision making in outpatient forensic psychiatry. BMC Psychiatry, 15: 120-015-0500-3. [Volledige tekst]

Dam van DS, Nierop van M, Viechtbauer W, Velthorst E, Winkel van R, Genetic Risk and Outcome of Psychosis (GROUP) investigators, Bruggeman R, Cahn W, Haan de L, Kahn RS, Meijer CJ, Myin-Germeys I, Os van J, Wiersma D. (2015). Childhood abuse and neglect in relation to the presence and persistence of psychotic and depressive symptomatology. Psychological Medicine, 45: 1363-1377. [Volledige tekst]

Islam MA, Alizadeh BZ, Heuvel van den ER, GROUP Investigators (Bruggeman R, Cahn W, Haan de L, Kahn RS, Meijer C, Myin-Germeys I, Os van J, Wiersma D. (2015). A comparison of indices for identifying the number of clusters in hierarchical clustering: A study on cognition in schizophrenia patients. Communications in Statistics, 1: 98-113. [Volledige tekst]

Maat A, Montfort van SJ, Nijs de J, Derks EM, Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I, GROUP Investigators. (2015). Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research, 161: 392-398. [Volledige tekst]

Schirmbeck F, Boyette LL, Valk van der R, Meijer C, Dingemans P, Van R, Haan de L, GROUP, Kahn RS, Haan de L, Os van J, Wiersma D, Bruggeman R, Cahn W, Meijer C, Myin-Germeys I. (2015). Relevance of Five-Factor Model personality traits for obsessive-compulsive symptoms in patients with psychotic disorders and their un-affected siblings. Psychiatry Research, 225: 464-470. [Volledige tekst]

Velde van der J, Gromann PM, Swart M, Haan de L, Wiersma D, Bruggeman R, Krabbendam L, Aleman A. (2015). Grey matter, an endophenotype for schizophrenia? A voxel-based morphometry study in siblings of patients with schizophrenia. Journal of Psychiatry & Neuroscience; 40: 207-213. [Volledige tekst]

Velde van der J, Gromann PM, Swart M, Wiersma D, Haan de L, Bruggeman R, Krabbendam L, Aleman A. (2015). Alexithymia influences brain activation during emotion perception but not regulation. Social Cognitive and Affective Neuroscience, 10: 285-293. [Volledige tekst]

Velde van der J, Swart M, Rijn van S, Meer van der L, Wunderink L, Wiersma D, Krabbendam L, Bruggeman R, Aleman A. (2015). Cognitive alexithymia is associated with the degree of risk for psychosis. PloS One, 10: e0124803. [Volledige tekst]

Wiersma D, Visser E, Bahler M, Bruggeman R, Delespaul PA, Gaag van der M, Haan de L, Keet IP, Nijssen Y, Os van J, Pijnenborg GH, Slooff C, Swildens W, Vos de AE, Weeghel van J, Wunderink L, Mulder CL. (2015). Functional remission of people with serious mental illness (SMI): psychometric properties of a new ROM-instrument. Tijdschrift voor Psychiatrie, 57: 395-404. [Volledige tekst]

Aleman A, Velde van der J, Gromann P, Swart M, Haan de L, Wiersma D, Krabbendam L, Bruggeman R. (2014). Alexithymia and Emotion Regulation Strategies in First-degree Relatives of Schizophrenia Patients. Schizophrenia Research. 153 Suppl.1:

Apeldoorn SY, Sterk B, Heuvel van den ER, Schoevers RA, Islam MA, Genetic Risk and Outcome of Psychosis (GROUP) Investigators, Bruggeman R, Cahn W, Haan de L, Kahn RS, Meijer CJ, Myin-Germeys I, Os van J, Wiersma D. (2014). Factors contributing to the duration of untreated psychosis. Schizophrenia research, 158: 76-81. [Volledige tekst]

Boer de MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. (2014). A systematic review of instruments to measure sexual functioning in patients using antipsychotics. Journal of Sex Research, 51: 383-389. [Volledige tekst]

Boer de MK, Oolders JM, Heuvel van den ER, Wiersma D, Schoevers RA, Knegtering H. (2014). Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind, placebo-controlled, crossover pilot study. Journal of Clinical Psychopharmacology, 34: 380-382. [Volledige tekst]

Borglum AD, Demontis D, Grove J, Pallesen J, Hollegaard MV, Pedersen CB, Hedemand A, Mattheisen M, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Uitterlinden A, Nyegaard M, Orntoft T, Wiuf C, Didriksen M, Nordentoft M, Nothen MM, Rietschel M, Ophoff RA, Cichon S, Yolken RH, Hougaard DM, Mortensen PB, Mors O. (2014). Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Molecular Psychiatry, 19: 325-333. [volledige tekst]

Boyette LL, Korver-Nieberg N, Meijer C, Haan de L, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2014). Quality of life in patients with psychotic disorders: impact of symptoms, personality, and attachment. Journal of Nervous and Mental Disease, 202: 64-69. [volledige tekst]

Boyette LL, van Dam D, Meijer C, Velthorst E, Cahn W, de Haan L, GROUP, Kahn R, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W, Meijer C, Myin-Germeys I. (2014). Personality compensates for impaired quality of life and social functioning in patients with psychotic disorders who experienced traumatic events. Schizophrenia bulletin, 40: 1356-1365. Nov

Lataster T, Verweij K, Viechtbauer W, GROUP (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2014). Effect of illness expression and liability on familial associations of clinical and subclinical psychosis phenotypes. Acta Psychiatrica Scandinavica, 129: 44-53. [volledige tekst]

Maat A, Montfort van SJ, Nijs de J, Derks EM, Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I, GROUP Investigators. (2014). Emotion processing in schizophrenia is state and trait dependent. Schizophrenia research, [volledige tekst]

Meer van der L, Swart M, Velde van der J, Pijnenborg G, Wiersma D, Bruggeman R, Aleman A. (2014). Neural correlates of emotion regulation in patients with schizophrenia and non-affected siblings. PloS one, 9: e99667. [Volledige tekst]

Psychosis Endophenotypes International Consortium, Wellcome Trust Case-Control Consortium 2, Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, Gray E, Dronov S, Potter SC, Tashakkori-Ghanbaria A, Edkins S, Bumpstead SJ, Arranz MJ, Bakker S, Bender S, Bruggeman R, Cahn W, Chandler D, Collier DA, Crespo-Facorro B, Dazzan P, Haan de L, Di Forti M, Dragovic M, Giegling I, Hall J, Iyegbe C, Jablensky A, Kahn RS, Kalaydjieva L, Kravariti E, Lawrie S, Linszen DH, Mata I, McDonald C, McIntosh A, Myin-Germeys I, Ophoff RA, Pariante CM, Paunio T, Picchioni M, Psychiatric Genomics Consortium, Ripke S, Rujescu D, Sauer H, Shaikh M, Sussmann J, Suvisaari J, Tosato S, Toulopoulou T, Os van J, Walshe M, Weisbrod M, Whalley H, Wiersma D, Blackwell JM, Brown MA, Casas JP, Corvin A, Duncanson A, Jankowski JA, Markus HS, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Wood NW, Barroso I, Peltonen L, Lewis CM, Murray RM, Donnelly P, Powell J, Spencer CC. (2014). A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry, 75: 386-397. [Volledige tekst]

Quee PJ, Alizadeh BZ, Aleman A, Heuvel van den ER, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2014). Cognitive subtypes in non-affected siblings of schizophrenia patients: characteristics and profile congruency with affected family members. Psychological Medicine, 44: 395-405. [volledige tekst]

Quee PJ, Meer van der L, Krabbendam L, Haan de L, Cahn W, Wiersma D, Beveren van N, Pijnenborg GH, Mulder CL, Bruggeman R, Aleman A. (2014). Insight change in psychosis: relationship with neurocognition, social cognition, clinical symptoms and phase of illness. Acta Psychiatrica Scandinavica, 129: 126-133. [Volledige tekst]

Redmeijer J, Quee P, Stiekema A, Wigman J, Schneider H, Meer van der L, Maples N, Wiersma D, Heuvel van den E, Velligan D, Bruggeman R. (2014). Improving Functional Outcomes for Schizophrenia Patients in the Netherlands using Cognitive Adaptation Training as a Nursing Intervention – A Pilot Study. Schizophrenia Research. 153 Suppl.1:

Swart M, Boer de M, Wiersma D, Schoevers R, Knegtering H. (2014). Sexual Side Effects in Patients Using Long-acting Depot Antipsychotics. Schizophrenia Research. 153 Suppl.1:

Velde van der J, Gromann P, Swart M, Haan de L, Bruggeman R, Wiersma D, Krabbendam L, Aleman A. (2014). Is Gray Matter Volume a Structural Endophenotype for Schizophrenia? Schizophrenia Research. 153 Suppl.1:

Velde van der J, Tol van MJ, Goerlich-Dobre KS, Gromann PM, Swart M, Haan de L, Wiersma D, Bruggeman R, Krabbendam L, Aleman A. (2014). Dissociable morphometric profiles of the affective and cognitive dimensions of alexithymia. Cortex, 54: 190-199. [volledige tekst]

Won S, Kwon MS, Mattheisen M, Park S, Park C, Kihara D, Cichon S, Ophoff R, Nothen MM, Rietschel M, Baur M, Uitterlinden AG, Hofmann A, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Lange C. (2014). Efficient strategy for detecting gene x gene joint action and its application in schizophrenia. Genetic Epidemiology, 38: 60-71. [Volledige tekst]

Berg van den SM, Paap MC, Derks EM, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Using multidimensional modeling to combine self-report symptoms with clinical judgment of schizotypy. Psychiatry Res. 206: 75-80 [PubMed]

Boer de MK, Castelein S, Bous J, Heuvel van den ER, Wiersma D, Schoevers RA, Knegtering H. (2013). The Antipsychotics and Sexual Functioning Questionnaire (ASFQ): preliminary evidence for reliability and validity. Schizophr.Res. 150: 410-5 [PubMed]

Boerhout C, Busschbach van JT, Wiersma D, Hoek HW. (2013). Psychomotor therapy and aggression regulation in eating disorders. Body, Movement and Dance in Psychotherapy. 8: 241-53 [Artikel]

Boyette LL, Korver-Nieberg N, Verweij K, Meijer C, Dingemans P, Cahn W, Haan de L, GROUP (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Associations between the Five-Factor Model personality traits and psychotic experiences in patients with psychotic disorders, their siblings and controls. Psychiatry Res. 210: 491-7 [PubMed]

Dekker N, Swets M, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Substance use in a large sample of patients with schizophrenia or related disorders and co-morbid obsessive-compulsive symptoms. Aust.N.Z.J.Psychiatry. 47: 868-74 [PubMed]

Derks EM, Ophoff RA, Genetic Risk Outcome of Psychosis (GROUP: Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Replication and refinement of the role of rs548181 in schizophrenia: results from a family based study. Am.J.Med.Genet.B.Neuropsychiatr.Genet. 162: 75-7 [PubMed]

Fett AK, Maat A, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Social cognitive impairments and psychotic symptoms: what is the nature of their association?. Schizophr.Bull. 39: 77-85 [PubMed]

Heering HD, Haren van NE, Derks EM, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). A two-factor structure of first rank symptoms in patients with a psychotic disorder. Schizophr.Res. 147: 269-74 [PubMed]

Klaassen RM, Heins M, Luteijn LB, Gaag van der M, Beveren van NJ, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controls. Psychol.Med. 43: 747-56 [PubMed]

Knapp M, Patel A, Curran C, Latimer E, Catty J, Becker T, Drake RE, Fioritti A, Kilian R, Lauber C, Rössler W, Tomov T, Busschbach van J, Comas-Herrera A, White S, Wiersma D, Burns T. (2013). Supported employment: cost-effectiveness across six European sites. World Psychiatry. 12: 60-8 [PubMed]

Lako IM, Bruggeman R, Liemburg EJ, Heuvel van den ER, Knegtering H, Slooff CJ, Wiersma D, Taxis K. (2013). A brief version of the Subjects’ Response to Antipsychotics questionnaire to evaluate treatment effects. Schizophr.Res. 147: 175-80 [PubMed]

Meijer JH, Swets M, Keeman S, Nieman DH, Meijer CJ, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Is a schizo-obsessive subtype associated with cognitive impairment? Results from a large cross-sectional study in patients with psychosis and their unaffected relatives. J.Nerv.Ment.Dis. 201: 30-5 [PubMed]

Nierop van M, Janssens M, Genetic Risk OUtcome of Psychosis Investigators, Bruggeman R, Cahn W, Haan de L, Kahn RS, Meijer CJ, Myin-Germeys I, Os van J, Wiersma D. (2013). Evidence that transition from health to psychotic disorder can be traced to semi-ubiquitous environmental effects operating against background genetic risk. PLoS One. 8: e76690 [PubMed]

Simons CJ, Winkel van R, GROUP (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2013). Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition. Schizophr.Bull. 39: 848-56 [PubMed]

Swart M, Liemburg EJ, Kortekaas R, Wiersma D, Bruggeman R, Aleman A. (2013). Normal brain activation in schizophrenia patients during associative emotional learning. Psychiatry Res. 214: 269-76 [PubMed]

Troquete NA, Brink van den RH, Beintema H, Mulder T, Os van TW, Schoevers RA, Wiersma D. (2013). Risk assessment and shared care planning in out-patient forensic psychiatry: cluster randomised controlled trial. Br.J.Psychiatry. 202: 365-71 [PubMed]

Troquete NA, Brink van den RH, Beintema H, Mulder T, Os van TW, Schoevers RA, Wiersma D. (2013). Little evidence for the use of structured risk assessment to reduce recidivism in forensic psychiatry. Authors’ reply. Br.J.Psychiatry. 202: 468-9 [PubMed]

Vinkers CH, Gastel van WA, Schubart CD, Eijk van KR, Luykx JJ, Winkel van R, Joels M, Ophoff RA, Boks MP, Genetic Risk and OUtcome of Psychosis (GROUP) Investigators, Bruggeman R, Cahn W, Haan de L, Kahn RS, Meijer CJ, Myin-Germeys I, Os van J, Wiersma D. (2013). The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val(1)(5)(8)Met polymorphism. Schizophr.Res. 150: 303-11 [PubMed]

Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry. 70: 913-20 [PubMed]

Bartels-Velthuis AA, Willige van de G, Jenner JA, Os van J, Wiersma D. (2012). Auditieve hallucinaties bij kinderen. In: Jenner JA (ed). Hallucinaties. Assen: Van Gorcum

Bartels-Velthuis AA, Willige van de G, Jenner JA, Wiersma D. (2012). Consistency and reliability of the auditory vocal hallucination rating scale (AVHRS). Epidemiol.Psychiatr.Sci. 21: 305-10 [PubMed]

Bartels-Velthuis AA, Willige van de G, Jenner JA, Wiersma D, Os van J. (2012). Auditory hallucinations in childhood: associations with adversity and delusional ideation. Psychol.Med. 42: 583-93 [PubMed]

Boonstra N, Klaassen R, Sytema S, Marshall M, Haan de L, Wunderink L, Wiersma D. (2012). Duration of untreated psychosis and negative symptoms–a systematic review and meta-analysis of individual patient data. Schizophr.Res. 142: 12-9 [PubMed]

Boonstra N, Sterk B, Wunderink L, Sytema S, Haan de L, Wiersma D. (2012). Association of treatment delay, migration and urbanicity in psychosis. Eur.Psychiatry. 27: 500-5 [PubMed]

Boonstra N, Sterk B, Wunderink L, Sytema S, Haan de L, Wiersma D. (2012). Association of treatment delay, migration and urbanicity in psychosis. Schizophr.Res. 136 Supp.1: S120 [Abstract]

Brink van den RH, Broer J, Tholen AJ, Winthorst WH, Visser E, Wiersma D. (2012). Role of the police in linking individuals experiencing mental health crises with mental health services. BMC Psychiatry. 12: 171,244X-12-171 [Volledige tekst]

Dekker N, Koeter M, Brink van den W, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale. Int.J.Methods Psychiatr.Res. 21: 286-300 [PubMed]

Dekker N, Meijer J, Koeter M, Brink van den W, Beveren van N, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I. (2012). Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychol.Med. 42: 1903-11 [PubMed]

Derks EM, Allardyce J, Boks MP, Vermunt JK, Hijman R, Ophoff RA, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Kraepelin was right: a latent class analysis of symptom dimensions in patients and controls. Schizophr.Bull. 38: 495-505 [PubMed]

Faber G, Smid HG, Gool van AR, Wiersma D, Bosch van den RJ. (2012). The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis. Eur.Psychiatry. 27: 275-80 [PubMed]

Faber G, Smid HG, Gool van AR, Wunderink L, Bosch van den RJ, Wiersma D. (2012). Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial. J.Clin.Psychiatry. 73: 632-8 [PubMed]

Gladwin TE, Derks EM, Genetic Risk and Outcome of Psychosis (GROUP: Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Rietschel M, Mattheisen M, Breuer R, Schulze TG, Nothen MM, Levinson D, Shi J, Gejman PV, Cichon S, Ophoff RA. (2012). Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples. PloS One. 7: e38828 [PubMed]

Heer de-Wunderink C, Visser E, Caro-Nienhuis A, Sytema S, Wiersma D. (2012). Supported Housing and Supported Independent Living in the Netherlands, with a Comparison with England. Community Ment.Health J. 48: 321-7 [PubMed]

Heer de-Wunderink C, Visser E, Caro-Nienhuis AD, Weeghel van J, Sytema S, Wiersma D. (2012). Treatment plans in psychiatric community housing programs: do they reflect rehabilitation principles? Psychiatr.Rehabil.J. 35: 454-9 [PubMed]

Heer de-Wunderink C, Visser E, Sytema S, Wiersma D. (2012). Social inclusion of people with severe mental illness living in community housing programs. Psychiatr.Serv. 63: 1102-7 [PubMed]

Kilian R, Lauber C, Kalkan R, Dorn W, Rössler W, Wiersma D, Busschbach van JT, Fioritti A, Tomov T, Catty J, Burns T, Becker T. (2012). The relationships between employment, clinical status, and psychiatric hospitalisation in patients with schizophrenia receiving either IPS or a conventional vocational rehabilitation programme. Soc.Psychiatry Psychiatr.Epidemiol. 47: 1381-9 [PubMed]

Killaspy H, White S, Wright C, Taylor TL, Turton P, Kallert T, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisova L, Onchev G, Alexiev S, Mezzina R, Ridente P, Wiersma D, Visser E, Kiejna A, Piotrowski P, Ploumpidis D, Gonidakis F, Caldas de Almeida JM, Cardoso G, King M. (2012). Quality of longer term mental health facilities in Europe: validation of the quality indicator for rehabilitative care against service users’ views. PloS One. 7: e38070 [PubMed]

Koning JP, Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh B, Harten van PN, Snieder H, Genetic Risk and Outcome in Psychosis (GROUP) investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients. Psychopharmacology. 219: 727-36 [PubMed]

Kortrijk HE, Mulder CL, Drukker M, Wiersma D, Duivenvoorden HJ. (2012). Duration of assertive community treatment and the interpretation of routine outcome data. Aust.N.Z.J.Psychiatry. 46: 240-8 [PubMed]

Kortrijk HE, Mulder CL, Gaag van der M, Wiersma D. (2012). Symptomatic and functional remission and its associations with quality of life in patients with psychotic disorder in Assertive Community Treatment teams. Compr.Psychiatry. 53: 1174-80 [PubMed]

Korver N, Quee PJ, Boos HB, Simons CJ, Haan de L, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int.J.Methods Psychiatr.Res. 21: 205-21 [PubMed]

Krieke van der L, Emerencia AC, Wunderink L, Wiersma D, Sytema S. (2012). E-mental health care applications supporting self-management in people with a psychotic disorder: a systematic review of the literature. Schizophr.Res. 136 Supp.1: S343 [Abstract]

Lako IM, Bruggeman R, Knegtering H, Wiersma D, Schoevers RA, Slooff CJ, Taxis K. (2012). A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. J.Affect.Disord. 140: 38-47 [PubMed]

Lako IM, Taxis K, Bruggeman R, Knegtering H, Burger H, Wiersma D, Slooff CJ. (2012). The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. Eur.Psychiatry. 27: 240-4 [PubMed]

Lataster T, Shazad A, Henquet C, Quee P, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). No evidence for familial covariation of neurocognition and negative symptoms in psychotic disorders. Schizophr.Res. 139: 271-2 [PubMed]

Maat A, Fett AK, Derks E, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Social cognition and quality of life in schizophrenia. Schizophr.Res. 137: 212-8 [PubMed]

Machielsen M, Scheltema Beduin A, Dekker N, Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I. (2012). Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. J.Psychopharmacol. 26: 189-95 [PubMed]

McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Rössler W, Salize HJ, Svensson B, Torres-Gonzalez F, Brink van den R, Wiersma D, Priebe S. (2012). The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PloS One. 7: e36080 [PubMed] [Artikel]

Meijer J, Simons CJ, Quee PJ, Verweij K, GROUP Investigators (Kahn RS, Cahn W, Linszen DH, Haan de L, Os van J, Krabbendam L, Myin-Germeys I, Wiersma D, Bruggeman R, Os van J). (2012). Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents. Acta Psychiatr.Scand. 125: 66-76 [PubMed]

Meijer JH, Dekker N, Koeter MW, Quee PJ, Beveren van NJ, Meijer CJ, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychol.Med. 42: 705-16 [PubMed]

Muhleisen TW, Mattheisen M, Strohmaier J, Degenhardt F, Priebe L, Schultz CC, Breuer R, Meier S, Hoffmann P, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Rivandeneira F, Hofman A, Uitterlinden AG, Moebus S, Gieger C, Emeny R, Ladwig KH, Wichmann HE, Schwarz M, Kammerer-Ciernioch J, Schlosser RG, Nenadic I, Sauer H, Mossner R, Maier W, Rujescu D, Lange C, Ophoff RA, Schulze TG, Rietschel M, Nothen MM, Cichon S. (2012). Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr.Res. 138: 69-73 [PubMed]

Quee PJ, Schneider H, Slogteren van S, Wiersma D, Bruggeman R, Velligan DI. (2012). Cognitive adaptation training provided to chronically hospitalized patients with schizophrenia in the Netherlands: two case reports. Case Rep.Psychiatry. 2012: 596162 [PubMed]

Quee PJ, Wiersma D, Sytema S, Bruggeman R. (2012). Cognitive adaptation training combined with assertive community treatment: a randomised longitudinal trial–a comment. Schizophr.Res. 140: 264-5 [PubMed]

Rietschel M, Mattheisen M, Degenhardt F, Genetic Risk and Outcome in Psychosis (GROUP) Investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Muhleisen TW, Kirsch P, Esslinger C, Herms S, Demontis D, Steffens M, Strohmaier J, Haenisch B, Breuer R, Czerski PM, Giegling I, Strengman E, Schmael C, Mors O, Mortensen PB, Hougaard DM, Orntoft T, Kapelski P, Priebe L, Basmanav FF, Forstner AJ, Hoffman P, Meier S, Nikitopoulos J, Moebus S, Alexander M, Mossner R, Wichmann H, Schreiber S, Rivandeneira F, Hofman A, Uitterlinden AG, Wienker TF, Schumacher J, Hauser J, Maier W, Cantor RM, Erk S, Schulze TG, SGENE-plus Consortium, Craddock N, Owen MJ, O’Donovan MC, Borglum AD, Rujescu D, Walter H, Meyer-Lindenberg A, Nothen MM, Ophoff RA, Cichon S. (2012). Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol.Psychiatry. 17: 906-17 [PubMed]

Rietschel M, Mattheisen M, Degenhardt F, GROUP Investigators (Kahn RS, Linszen DH, Os JV, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I, Muhleisen TW, Kirsch P, Esslinger C, Herms S, Demontis D, Steffens M, Strohmaier J, Haenisch B, Breuer R, Czerski PM, Giegling I, Strengman E, Schmael C, Mors O, Mortensen PB, Hougaard DM, Orntoft T, Kapelski P, Priebe L, Basmanav FB, Forstner AJ, Hoffmann P, Meier S, Nikitopoulos J, Moebus S, Alexander M, Mossner R, Wichmann HE, Schreiber S, Rivandeneira F, Hofman A, Uitterlinden AG, Wienker TF, Schumacher J, Hauser J, Maier W, Cantor RM, Erk S, Schulze TG, SGENE-plus Consortium, (Only those persons responsible for the samples of Replication 2 are listed), Stefansson H, Steinberg S, Gustafsson O, Sigurdsson E, Petursson H, Kong A, Stefansson K, Pietilainen OP, Tuulio-Henriksson A, Paunio T, Lonnqvist J, Suvisaari J, Peltonen L, Ruggeri M, Tosato S, Walshe M, Murray R, Collier DA, Clair DS, Hansen T, Ingason A, Jakobsen KD, Duong L, Werge T, Melle I, Andreassen OA, Djurovic S, Bitter I, Rethelyi JM, Abramova L, Kaleda V, Golimbet V, Jonsson EG, Terenius L, Agartz I, Winkel RV, Kenis G, Hert MD, Veldink J, Wiuf C, Didriksen M, Craddock N, Owen MJ, O’Donovan MC, Borglum AD, Rujescu D, Walter H, Meyer-Lindenberg A, Nothen MM, Ophoff RA, Cichon S. (2012). Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol.Psychiatry. 17: 906-17 [PubMed]

Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh BZ, Snieder H, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes. Eur.Neuropsychopharmacol. 22: 625-31 [PubMed]

Werf van der M, Kohler S, Verkaaik M, Verhey F, Os van J, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2012). Cognitive functioning and age at onset in non-affective psychotic disorder. Acta Psychiatr.Scand. 126: 274-81 [PubMed]

Wunderink L, Delespaul P, Gaag van der M, Haan de L, Linszen D, Mulder N, Os van J, Veling W, Weeghel van J, Wiersma D. (2012). Measuring functional remission: A tool for clinical practice and preliminary data on symptomatic and functional remission and recovery. Early Intervention in Psychiatry. 6 Supp.1: 113

Wunderink L, Nieboer R, Nienhuis F, Sytema S, Wiersma D. (2012). Remission, relapse and recovery following early guided discontinuation of antipsychotics versus maintenance treatment in first-episode psychosis: outcome at 7-year follow-up. Early Intervention in Psychiatry. 6 Supp.1: 20

Wunderink L, Nieboer R, Nienhuis F, Sytema S, Wiersma D. (2012). Remission, relapse and recovery following early guided discontinuation of antipsychotics versus maintenance treatment in first-episode psychosis: outcome at 7-year follow-up; Stand-in for Swaran Singh. Early Intervention in Psychiatry. 6 Supp.1: 16

Wunderink L, Nieboer R, Nienhuis FJ, Sytema S, Wiersma D. (2012). Long term impact of a discontinuation trial: remission and recovery rates at 7 years follow-up of a first episode cohort included in a treatment strategy trial comparing maintenance treatment with discontinuation strategy. Schizophr.Res. 136 Supp.1: S348 [Abstract]

Aerts LC, Busschbach van JT, Wiersma D. (2011). Vaktherapie in Noord Nederland, een beschrijving van de beroepspraktijk, behandeleffecten en tevredenheid van patiënten met vaktherapie binnen de noordelijke geestelijke gezondheidszorg. Groningen: Rob Giel Onderzoekcentrum. Verschenen als deel 28 in de RGOc-reeks

Bartels-Velthuis AA, Willige van de G, Jenner JA, Os van J, Wiersma D. (2011). Course of auditory vocal hallucinations in childhood: 5-year follow-up study. Br.J.Psychiatry. 199: 296-302 [PubMed]

Bartels-Velthuis AA, Willige van de G, Jenner JA, Os van J, Wiersma D. (2011). Risk factors of auditory hallucinations in childhood: trauma, adversity and the formation of psychotic-like ideation. Schizophr.Bull. 37 S1: 47

Boer de MK, Wiersma D, Bous J, Sytema S, Moolen van der AE, Wilffert B, Hamamura T, Knegtering H. (2011). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). J.Clin.Psychopharmacol. 31: 523-5 [PubMed]

Boerhout C, Busschbach van JT, Wiersma D, Hoek HW. (2011). Electronic letter: Re: Re: Do we need to treat aggression? Br.J.Psychiatry. 198: 408a Letter

Boyette L, Swets M, Meijer C, Wouters L, G.R.O.U.P. Authors (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2011). Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms. Psychiatry Res. 186: 409-13 [PubMed]

Brink van den R, Wiersma D, Wolters K, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, McCabe R, Rössler W, Salize H, Svensson B, Torres-Gonzales F, Priebe S. (2011). Non-uniform effectiveness of structured patient-clinician communication in community mental healthcare: an international comparison. Soc.Psychiatry Psychiatr.Epidemiol. 46: 685-93 [PubMed]

Busschbach van JT, Swildens W, Michon H, Kroon H, Os van J, Wiersma D. (2011). Succesvol met de Individuele Rehabilitatie Benadering. Over verschillen in de effectiviteit van rehabilitatietrajecten. In: Rooijen van S, Weeghel van J (eds). Psychiatrische Rehabilitatie Jaarboek 2010-2011. Utrecht: Kenniscentrum Phrenos

Caro-Nienhuis AD, Visser E, Weeghel van J, Killaspy H, Wright C, Wiersma D. (2011). Perspectieven op herstelgerichte woonzorg: Nederlandse bevindingen in een Europese Delphi-studie. Tijdschr Rehabil. 2: 20-61

Catty J, White S, Koletsi M, Becker T, Fioritti A, Kalkan R, Lauber C, Lissouba P, Rössler W, Tomov T, Busschbach van JT, Wiersma D, Burns T, EQOLISE Group. (2011). Therapeutic relationships in vocational rehabilitation: Predicting good relationships for people with psychosis. Psychiatry Res. 187: 68-73 [PubMed]

Chen X, Lee G, Maher BS, Fanous AH, Chen J, Zhao Z, Guo A, Oord van den E, Sullivan PF, Shi J, Levinson DF, Gejman PV, Sanders A, Duan J, Owen MJ, Craddock NJ, O’Donovan MC, Blackman J, Lewis D, Kirov GK, Qin W, Schwab S, Wildenauer D, Chowdari K, Nimgaonkar V, Straub RE, Weinberger DR, O’Neill FA, Walsh D, Bronstein M, Darvasi A, Lencz T, Malhotra AK, Rujescu D, Giegling I, Werge T, Hansen T, Ingason A, Noethen MM, Rietschel M, Cichon S, Djurovic S, Andreassen OA, Cantor RM, Ophoff R, Corvin A, Morris DW, Gill M, Pato CN, Pato MT, Macedo A, Gurling HM, McQuillin A, Pimm J, Hultman C, Lichtenstein P, Sklar P, Purcell SM, Scolnick E, St.Clair D, Blackwood DH, Kendler KS, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), International Schizophrenia Consortium. (2011). GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol.Psychiatry. 16: 1117-29 Nov

Collip D, Nicolson NA, Lardinois M, Lataster T, Os van J, Myin-Germeys I, GROUP (Kahn RS, Linszen DH, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L). (2011). Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol.Med. 41: 2305-15 [PubMed]

Ende van der PC, Busschbach van JT, Wiersma D, Korevaar EL. (2011). Parents with severe mental illness. Epidemiological data. Tijdschr.Psychiatr. 53: 851-6 [PubMed]

Es van FD, Knegtering H, Carbo M, Smid HG, Wiersma D, Bruggeman R. (2011). Gender differences in first episode psychosis- the EPO 500 study. Schizophrenia Bulletin. 37 Suppl.1: 65

Faber G, Gool van AR, Smid HG, Wiersma D, Bosch van den RJ. (2011). Typische en atypische antipsychotica bij patiënten met schizofrenie: is er verschil in invloed op neurocognitie? [Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?]. Tijdschr.Psychiatr. 53: 107-17 [PubMed]

Faber G, Smid HG, Gool van AR, Wunderink L, Wiersma D, Bosch van den RJ. (2011). Neurocognition and recovery in first episode psychosis. Psychiatry Res. 188: 1-6 [PubMed]

Gaag van der M, Stant AD, Wolters KJ, Buskens E, Wiersma D. (2011). Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis. Br.J.Psychiatry. 198: 59,65, sup 1 [PubMed]

Genetic Risk and Outcome in Psychosis (GROUP) Investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2011). Evidence That Familial Liability for Psychosis Is Expressed as Differential Sensitivity to Cannabis: An Analysis of Patient-Sibling and Sibling-Control Pairs. Arch.Gen.Psychiatry. 68: 132-47 [PubMed]

Habets P, Marcelis M, Gronenschild E, Drukker M, Os van J, Genetic Risk and Outcome of Psychosis (GROUP: Kahn,R.S., Linszen DH, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2011). Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol.Psychiatry. 69: 487-94 [PubMed]

Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, Pietilainen OP, Buizer-Voskamp JE, Strengman E, Francks C, Muglia P, Gylfason A, Gustafsson O, Olason PI, Steinberg S, Hansen T, Jakobsen KD, Rasmussen HB, Giegling I, Moller HJ, Hartmann A, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Bramon E, Kiemeney LA, Franke B, Murray R, Vassos E, Toulopoulou T, Muhleisen TW, Tosato S, Ruggeri M, Djurovic S, Andreassen OA, Zhang Z, Werge T, Ophoff RA, GROUP Investigators (Kahn RS, Cahn W, Linszen D, Haan de L, Os van J, Krabbendam L, Myin-Germeys I, Wiersma D, Bruggeman R), Rietschel M, Nothen MM, Petursson H, Stefansson H, Peltonen L, Collier D, Stefansson K, St Clair DM. (2011). Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol.Psychiatry. 16: 17-25 [PubMed]

Killaspy H, White S, Wright C, Taylor TL, Turton P, Schutzwohl M, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisova L, Onchev G, Alexiev S, Mezzina R, Ridente P, Wiersma D, Visser E, Kiejna A, Adamowski T, Ploumpidis D, Gonidakis F, Caldas de Almeida J, Cardoso G, King MB. (2011). The development of the Quality Indicator for Rehabilitative Care (QuIRC): a measure of best practice for facilities for people with longer term mental health problems. BMC Psychiatry. 11: 35 [PubMed]

Korver-Nieberg N, Quee PJ, Boos HB, Simons CJ, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Krabbendam L, Myin-Germeys I, Wiersma D, Bruggeman R). (2011). The validity of the DSM-IV diagnostic classification system of non-affective psychoses. Aust.N.Z.J.Psychiatry. 45: 1061-8 [PubMed]

Krieke van der L, Sytema S, Wiersma D, Tielen H, Hemert van AM. (2011). Evaluating the CANSAS self-report (CANSAS-P) as a screening instrument for care needs in people with psychotic and affective disorders. Psychiatry Res. 188: 456-8 [PubMed]

Looman N, Knegtering H, Slooff CJ, Jörg F, Lako IM, Sytema S, Wiersma D, Taxis K, Bruggeman R. (2011). Somatische screening als onderdeel van de ROM-psychosen; haalbaarheid en resultaten binnen het Phamous-project in Noord-Nederland [Screening for somatic diseases as part of Routine Outcome Monitoring]. Tijdschrift voor Psychiatrie. 53 Suppl.1: 110-1

Quee PJ, Bruggeman R, Schneider H, Velligan DI, Wiersma D. (2011). Cognitieve Adaptatie Training. In: Pijnenborg GHM, Withaar FK, Slooff CJ, Knegtering H, Gaag van der M (eds). Negatieve symptomen en cognitieve functiestoornissen bij schizofrenie en verwante psychosen. Utrecht: Kenniscentrum Phrenos

Quee PJ, Meer van der L, Bruggeman R, Haan de L, Krabbendam L, Cahn W, Mulder NC, Wiersma D, Aleman A. (2011). Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness. Schizophr.Bull. 37: 29-37 [PubMed]

Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, Lin DY, Duan J, Ophoff RA, Andreassen OA, Scolnick E, Cichon S, St.Clair D, Corvin A, Gurling H, Werge T, Rujescu D, Blackwood DH, Pato CN, Malhotra AK, Purcell S, Dudbridge F, Neale BM, Rossin L, Visscher PM, Posthuma D, Ruderfer DM, Fanous A, Stefansson H, Steinberg S, Mowry BJ, Golimbet V, Hert de M, Jonsson EG, Bitter I, Pietilainen OP, Collier DA, Tosato S, Agartz I, Albus M, Alexander M, Amdur RL, Amin F, Bass N, Bergen SE, Black DW, Borglum AD, Brown MA, Bruggeman R, Buccola NG, Byerley WF, Cahn W, Cantor RM, Carr VJ, Catts SV, Choudhury K, Cloninger CR, Cormican P, Craddock N, Danoy PA, Datta S, Haan de L, Demontis D, Dikeos D, Djurovic S, Donnelly P, Donohoe G, Duong L, Dwyer S, Fink-Jensen A, Freedman R, Freimer NB, Friedl M, Georgieva L, Giegling I, Gill M, Glenthoj B, Godard S, Hamshere M, Hansen M, Hansen T, Hartmann AM, Henskens FA, Hougaard DM, Hultman CM, Ingason A, Jablensky AV, Jakobsen KD, Jay M, Jurgens G, Kahn RS, Keller MC, Kenis G, Kenny E, Kim Y, Kirov GK, Konnerth H, Konte B, Krabbendam L, Krasucki R, Lasseter VK, Laurent C, Lawrence J, Lencz T, Lerer FB, Liang KY, Lichtenstein P, Lieberman JA, Linszen DH, Lonnqvist J, Loughland CM, Maclean AW, Maher BS, Maier W, Mallet J, Malloy P, Mattheisen M, Mattingsdal M, McGhee KA, McGrath JJ, McIntosh A, McLean DE, McQuillin A, Melle I, Michie PT, Milanova V, Morris DW, Mors O, Mortensen PB, Moskvina V, Muglia P, Myin-Germeys I, Nertney DA, Nestadt G, Nielsen J, Nikolov I, Nordentoft M, Norton N, Nothen MM, O’Dushlaine CT, Olincy A, Olsen L, O’Neill FA, Orntoft TF, Owen MJ, Pantelis C, Papadimitriou G, Pato MT, Peltonen L, Petursson H, Pickard B, Pimm J, Pulver AE, Puri V, Quested D, Quinn EM, Rasmussen HB, Rethelyi JM, Ribble R, Rietschel M, Riley BP, Ruggeri M, Schall U, Schulze TG, Schwab SG, Scott RJ, Shi J, Sigurdsson E, Silverman JM, Spencer CC, Stefansson K, Strange A, Strengman E, Stroup TS, Suvisaari J, Terenius L, Thirumalai S, Thygesen JH, Timm S, Toncheva D, Oord van den E, Os van J, Winkel van R, Veldink J, Walsh D, Wang AG, Wiersma D, Wildenauer DB, Williams HJ, Williams NM, Wormley B, Zammit S, Sullivan PF, O’Donovan MC, Daly MJ, Gejman PV, Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nat.Genet. 43: 969-76 [PubMed]

Stant AD, Castelein S, Bruggeman R, Busschbach van JT, Gaag van der M, Knegtering H, Wiersma D. (2011). Economic aspects of peer support groups for psychosis. Community Ment.Health J. 47: 99-105 [PubMed]

Steinberg S, Mors O, Borglum AD, Gustafsson O, Werge T, Mortensen PB, Andreassen OA, Sigurdsson E, Thorgeirsson TE, Bottcher Y, Olason P, Ophoff RA, Cichon S, Gudjonsdottir IH, Pietilainen OP, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Athanasiu L, Suvisaari J, Lonnqvist J, Paunio T, Hartmann A, Jurgens G, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Breuer R, Moller HJ, Giegling I, Glenthoj B, Rasmussen HB, Mattheisen M, Bitter I, Rethelyi JM, Sigmundsson T, Fossdal R, Thorsteinsdottir U, Ruggeri M, Tosato S, Strengman E, Genetic Risk and Outcome in Psychosis (GROUP) Investigators (Kahn,R.S., Cahn W, Linszen DH, Haan de L, Os van J, Krabbendam L, Myin-Germeys I, Wiersma D, Bruggeman R), Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Walshe M, Bramon E, Vassos E, Li T, Fraser G, Walker N, Toulopoulou T, Yoon J, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Peltonen L, Rujescu D, Collier DA, Stefansson H, St.Clair D, Stefansson K. (2011). Expanding the range of ZNF804A variants conferring risk of psychosis. Mol.Psychiatry. 16: 59-66 [PubMed]

Swart M, Bruggeman R, Laroi F, Alizadeh BZ, Kema I, Kortekaas R, Wiersma D, Aleman A. (2011). COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems. Neuroimage. 55: 338-44 [PubMed]

Swildens W, Busschbach van JT, Michon H, Kroon H, Koeter MW, Wiersma D, Os van J. (2011). Effectively working on rehabilitation goals: 24-month outcome of a randomized controlled trial of the Boston psychiatric rehabilitation approach. Can.J.Psychiatry. 56: 751-60 [PubMed]

Vehof J, Al Hadithy AF, Burger H, Snieder H, Risselada AJ, Wilffert B, Cohen D, Arends J, Wiersma D, Mulder H, Bruggeman R. (2011). Association between the ROBO1 gene and body mass index in patients using antipsychotics. Psychiatr.Genet. 21: 202-7 [PubMed]

Vehof J, Risselada AJ, Al Hadithy AF, Burger H, Snieder H, Wilffert B, Arends J, Wunderink L, Knegtering H, Wiersma D, Cohen D, Mulder H, Bruggeman R. (2011). Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication. Psychopharmacology. 216: 257-65 [Volledige tekst]

Weeghel van J, Lindt van de S, Slooff C, Kar van de F, Vugt van M, Wiersma D. (2011). A regional assessment of the quality of care for people with schizophrenia in The Netherlands. Psychiatr.Serv. 62: 789-92 [PubMed]

Wiersma D, Slooff CJ. (2011). Epidemiologie en beloop. In: Cahn W, Krabbendam L, Myin-Germeys I, Bruggeman R, Haan de L (eds). Handboek Schizofrenie. Utrecht: De Tijdstroom

Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, Georgieva L, Williams NM, Morris DW, Quinn EM, Giegling I, Ikeda M, Wood J, Lencz T, Hultman C, Lichtenstein P, Thiselton D, Maher BS, Molecular Genetics of Schizophrenia Collaboration (MGS) International Schizophrenia Consortium (ISC), SGENE-plus, GROUP Investigators (Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Malhotra AK, Riley B, Kendler KS, Gill M, Sullivan P, Sklar P, Purcell S, Nimgaonkar VL, Kirov G, Holmans P, Corvin A, Rujescu D, Craddock N, Owen MJ, O’Donovan MC. (2011). Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol.Psychiatry. 16: 429-41 [PubMed]

Winkel van R, Beveren van NJ, Simons C, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2011). AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder. Neuropsychopharmacology. 36: 2529-37 [PubMed]

Winkel van R, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (Kahn,R.S., Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I). (2011). Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up. Arch.Gen.Psychiatry. 68: 148-57 [PubMed]

Bartels-Velthuis AA, Jenner JA, Willige van de G, Os van J, Wiersma D. (2010). Prevalence and correlates of auditory vocal hallucinations in middle childhood. Br.J.Psychiatry. 196: 41-6 [PubMed]

Brink van den RH, Hooijschuur A, Os van TW, Savenije W, Wiersma D. (2010). Routine violence risk assessment in community forensic mental healthcare. Behav.Sci.Law. 28: 396-410 [PubMed]

Caro-Nienhuis AD, Heer de-Wunderink C, Sytema S, Wiersma D. (2010). Ontwikkelingen in de RIBW. Tweede prevalentiemeting in het kader van het UTOPIA-onderzoek. Groningen: Rob Giel Onderzoekcentrum/RIBW Alliantie. Verschenen als deel 25 in de RGOc-reeks

Castelein S, Bruggeman R, Busschbach van JT, Gaag van der M, Stant D, Knegtering H, Wiersma D. (2010). Lotgenotengroepen voor mensen met een psychose verbeteren kwaliteit van leven. Ned Tijdschr Geneeskd. 154: A1768

Castelein S, Bruggeman R, Busschbach van JT, Knegtering H, Gaag van der M, Wiersma D. (2010). Predictors of successful participation in peer support groups for psychosis. Schizophr.Res. 117: 276-7

Catty J, Koletsi M, White S, Becker T, Fioritti A, Kalkan R, Lauber C, Lissouba P, Rossler W, Tomov T, Busschbach van JT, Wiersma D, Burns T. (2010). Therapeutic relationships: their specificity in predicting outcomes for people with psychosis using clinical and vocational services. Soc.Psychiatry Psychiatr.Epidemiol. 45: 1187-93 [PubMed]

Kortrijk HE, Mulder CL, Roosenschoon BJ, Wiersma D. (2010). Treatment outcome in patients receiving assertive community treatment. Community Ment.Health J. 46: 330-6 [PubMed]

Mulder CL, Gaag van der M, Bruggeman R, Cahn W, Delespaul PA, Dries P, Faber G, Haan de L, Heijden van der FM, Kempen RW, Mogendorff ES, Slooff CJ, Sytema S, Wiersma D, Wunderink L, Os van J. (2010). Routine Outcome Monitoring for patients with severe mental illness: a consensus document. Tijdschr.Psychiatr. 52: 169-79 [PubMed]

Nienhuis FJ, Willige van de G, Rijnders CA, Jonge de P, Wiersma D. (2010). Validity of a short clinical interview for psychiatric diagnosis: the mini-SCAN. Br.J.Psychiatry. 196: 64-8 [PubMed]

Turton P, Wright C, White S, Killaspy H, DEMoBinc Group (Taylor LT, Schützwohl M, Cervilla JA, Brangier P, Raboch J, Onchev G, Mezzina R, Ridente P, Wiersma D, Caro-Nienhuis A, Kiejna A, Piotrowski P, Tzavelas E, Asimakopoulou X, Caldas-de-Almeida J, Cardoso G, King M). (2010). Promoting recovery in long-term institutional mental health care: an international Delphi study. Psychiatr.Serv. 61: 293-9 [PubMed]

Veling W, Hoek HW, Wiersma D, Mackenbach JP. (2010). Ethnic identity and the risk of schizophrenia in ethnic minorities: a case-control study. Schizophr.Bull. 36: 1149-56 [PubMed]

Wiersma D. (2010). Psychosocial interventions for psychoses. Ned.Tijdschr.Geneeskd. 154: A1760

Wiersma D, Becker T. (2010). Measuring social disability in mental health and employment outcomes. In: Thornicroft G, Tansella M (eds). Mental health Outcome measures. Third edition. London: RCPsych Publications

Boer de MK, Lammeren van AMDN, Wiersma D. (2009). Evaluatie van drie jaar dagdiagnostiek ADHD bij volwassenen. MGv.: 848-53

Boonstra N, Wunderink L, Sytema S, Wiersma D. (2009). Improving detection of first-episode psychosis by mental health-care services using a self-report questionnaire. Early Intervention in Psychiatry. 3: 289-95

Burns T, Catty J, White S, Becker T, Koletsi M, Fioritti A, Rossler W, Tomov T, Busschbach van J, Wiersma D, Lauber C. (2009). The impact of supported employment and working on clinical and social functioning: results of an international study of individual placement and support. Schizophr.Bull. 35: 949-58 [PubMed]

Gaag van der M, Stant D, Wolters K, Wiersma D. (2009). The cost-effectiveness of cognitive behavioral therapy for persistent and recurrent psychosis. Eur.Arch.Psychiatry Clin.Neurosci. 259: S58

Gleeson J, Linszen D, Wiersma D. (2009). Relapse Prevention in Early Psychosis. In: Jackson HJ, McGorry PD (eds). Recognition and Management of early Psychosis: a preventive approach, 2nd ed.

Heer de-Wunderink C, Visser E, Caro-Nienhuis AD, Sytema S, Wiersma D. (2009). De RIBW doet mee. Functioneren en tevredenheid van cliënten die woonbegeleiding ontvangen van de RIBW’s, de tweede fase van het UTOPIA-onderzoek. Groningen: Rob Giel Onderzoekcentrum/UMCG. Verschenen als deel 22 in de RGOc-reeks

Killaspy H, King M, Wright C, White S, McCrone P, Kallert T, Cervilla J, Raboch J, Onchev G, Mezzina R, Wiersma D, Kiejna A, Ploumpidis D, Caldas de Almeida JM. (2009). Study protocol for the development of a European measure of best practice for people with long term mental health problems in institutional care (DEMoBinc). BMC Psychiatry. 9: 36 [PubMed]

Knegtering H, Bous J, Sytema S, Wiersma D. (2009). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). [Report for the Rob Giel Research Center, Lentis Groningen and Bristol Myers Squibb]. In: Anonymous

Knegtering H, Ouwehand J, Sytema S, Wiersma D. (2009). Menstrual disorders in schizophrenia, possible causes and consequences. Schizophr.Res. 35: 64

Koletsi M, Niersman A, Busschbach van JT, Catty J, Becker T, Burns T, Fioritti A, Kalkan R, Lauber C, Rossler W, Tomov T, Wiersma D. (2009). Working with mental health problems: clients’ experiences of IPS, vocational rehabilitation and employment. Soc.Psychiatry Psychiatr.Epidemiol. Mar 12 [Epub ahead of print]: 970 [PubMed]

Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T, Picchioni M, Vassos E, Ettinger U, Bramon E, Murray R, Ruggeri M, Tosato S, Bonetto C, Steinberg S, Sigurdsson E, Sigmundsson T, Petursson H, Gylfason A, Olason PI, Hardarsson G, Jonsdottir GA, Gustafsson O, Fossdal R, Giegling I, Moller HJ, Hartmann A, Hoffmann P, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Andreassen OA, Djurovic S, Hansen T, Werge T, Melle I, Kiemeney LA, Franke B, Buizer-Voskamp JE, GROUP Investigators: ( Kahn RS, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germys I), Ophoff RA, Rietschel M, Nothen MM, Stefansson K, Peltonen L, St.Clair D, Stefansson H, Collier DA. (2009). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum.Mol.Genet. 18: 988-96 [PubMed]

Salize HJ, Mccabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Reinhard I, Rossler W, Svensson B, Torres-Gonzalez F, Brink van den R, Wiersma D, Priebe S. (2009). Cost of treatment of schizophrenia in six European countries. Schizophr.Res. 111: 70-7 [PubMed]

Stant D, Gaag van der M, Heeg B, Wiersma D, Buskens E. (2009). Cost-effectiveness of cognitive behavioural therapy for persistent and recurrent psychosis. J Ment Health Policy Econ. 12: S42

Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Genetic Risk and Outcome in Psychosis (GROUP) Consortium: (, Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germys I), Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, Frutos de R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St CD, Goldstein DB, Stefansson K, Collier DA. (2009). Common variants conferring risk of schizophrenia. Nature. 460: 744-7 [PubMed]

Taylor TL, Killaspy H, Wright C, Turton P, White S, Kallert TW, Schuster M, Cervilla JA, Brangier P, Raboch J, Kalisova L, Onchev G, Dimitrov H, Mezzina R, Wolf K, Wiersma D, Visser E, Kiejna A, Piotrowski P, Ploumpidis D, Gonidakis F, Caldas-de-Almeida J, Cardoso G, King MB. (2009). A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems. BMC Psychiatry. 9: 55 [PubMed]

Wiersma D, Brink van den R, Wolters K, Mccabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Rossler W, Salize H, Bjorkman T, Torres-Gonzales F, Wright DJ, Priebe S. (2009). Individual unmet needs for care: are they sensitive as outcome criterion for the effectiveness of mental health services interventions? Soc.Psychiatry Psychiatr.Epidemiol. 44: 317-24 [PubMed]

Wolters HA, Knegtering H, Bosch van den RJ, Wiersma D. (2009). Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Schizophr.Res. 112: 114-8 [PubMed]

Wolters HA, Wiersma D, Bosch van den RJ, Knegtering H. (2009). Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Schizophr.Res. 35: 35

Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. (2009). Clinical recovery in first-episode psychosis. Schizophr.Bull. 35: 362-9 [PubMed]

Bartels-Velthuis A, Jenner J, Willige van de G, Os van J, Wiersma D. (2008). Voice Hearing in Childhood: Prevalence rates and associations with obstetric complications, early development and social behaviour. Schizophr.Res. 102: 163

Bartels-Velthuis A, Willige van de G, Jenner J, Wiersma D. (2008). Assessing auditory vocal hallucinations: The psychometric evaluation of the Auditory Vocal Hallucination Rating Scale (AVHRS). Schizophr.Res. 102: 223-4

Boonstra N, Wunderink L, Hamar S, Sytema S, Wiersma D. (2008). Improving detection of first episode psychosis: Self-reported positive symptoms in first contacts with mental health care. Schizophr.Res. 98: 80

Boonstra N, Wunderink L, Sytema S, Wiersma D. (2008). Detection of psychosis by mental health care services; a naturalistic cohort study. Clin Pract Epidemol Ment Health. 4: 29 [PubMed]

Boonstra N, Wunderink L, Sytema S, Wiersma D. (2008). Improving detection of first episode psychoses by mental health care services: The results of first cntact screening with a self report questionnaire. Schizophr.Res. 102: 151

Boonstra N, Wunderink L, Wit de PH, Noorthoorn E, Wiersma D. (2008). De administratieve incidentie van niet-affectieve psychosen bij mannen en vrouwen in Friesland en Twente [The administrative incidence of non-affective psychoses in Friesland and Twente]. Tijdschr Psychiatr. 50: 637-43 [PubMed]

Broer J, Brink van den RHS, Tholen F, Winthorst W, Wiersma D. (2008). Politie als schakel in de OGGZ en de rol van crisisbeoordeling op het politiebureau. MGv. 63: 303-15 [artikel]

Burns T, Catty JG,C., Koletsi M, Lissouba P, Rinaldi M, White S, Becker T, Ehiosun U, Kalkan R, Kilian R, Fioritti A, Manchisi D, Niersman A, Busschbach van JT, Wiersma D, Lauber C, Rössler W, Warnke I, Germanov D, Tomov T, Comas A, Curran C, Knapp M, Patel A. (2008). IPS in Europe: the EQOLISE trial. Psychiatr.Rehabil.J. 31: 313-7 [PubMed]

Burns T, White SJ, Catty J, Geyer C, Koletsi M, Lissouba P, Rinaldi M, White S, Becker T, Ehiosun U, Kalkan R, Kilian R, Fioritti A, Manchisi D, Niersman A, Busschbach van JT, Wiersma D, Lauber C, Rössler W, Warnke I, Germanov D, Tomov T, Comas A, Curran C, Knapp M, Patel A. (2008). Individual Placement and Support in Europe: the EQOLISE trial. Int Rev.Psychiatry. 20: 498-502 [PubMed]

Busschbach van JT, Visser E, Sytema S, Wiersma D. (2008). Blijvend aan het werk. Onderzoek naar het langetermijnresultaat van arbeidsrehabilitatie bij DAAT-Drenthe. Maandbl Reïntegr. 8: 26-30

Castelein S, Bruggeman R, Busschbach van JT, Gaag van der M, Stant AD, Knegtering H, Wiersma D. (2008). The effectiveness of peer support groups in psychosis: a randomized controlled trial. Acta Psychiatr.Scand. 118: 64-72 [PubMed]

Castelein S, Gaag van der M, Bruggeman R, Busschbach van JT, Wiersma D. (2008). Measuring empowerment among people with psychotic disorders: a comparison of three instruments. Psychiatr.Serv. 59: 1338-42 [PubMed]

Catty J, Lissouba P, White S, Becker T, Drake RE, Fioritti A, Knapp M, Lauber C, Rossler W, Tomov T, Busschbach van J, Wiersma D, Burns T. (2008). Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. Br.J.Psychiatry. 192: 224-31 [PubMed]

European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions: Leboyer,M., Meyer-Lindenberg A, Stefanis N, Rutten BP, Arango C, Jones P, Kapur S, Lewis S, Murray R, Owen MJ, Linszen D, Kahn R, Os van J, Wiersma D, Bruggeman R, Cahn W, Germeys I, Haan de L, Krabbendam L. (2008). Schizophrenia aetiology: do gene-environment interactions hold the key? (Comment on Tandon et al. Schizophrenia Research 2008, vol 102, 1-18). [*Marion Leboyer, Andreas Meyer-Lindenberg, Nikos Stefanis, GROUP (Don Linszen, Rene Kahn, Jim van Os, Durk Wiersma and Richard Bruggeman, Wiepke Cahn, Inez Germeys, Lieuwe de Haan, Lydia Krabbendam), Bart P.F. Rutten, Celso Arango, Peter Jones, Shitij Kapur, Shôn Lewis, Robin Murray and Michael J. Owen]. Schizophr.Res. 102: 21-6 [PubMed]

Hansson L, Svensson B, Bjorkman T, Bullenkamp J, Lauber C, Martinez-Leal R, Mccabe R, Rossler W, Salize H, Torres-Gonzales F, Brink van den R, Wiersma D, Priebe S. (2008). What works for whom in a computer-mediated communication intervention in community psychiatry? Moderators of outcome in a cluster randomized trial. Acta Psychiatr.Scand. 118: 404-9 [PubMed]

Heer de-Wunderink C, Caro-Nienhuis AD, Sytema S, Wiersma D. (2008). Residential care: Dutch and Italian residents of residential care facilities compared. Epidemiol.Psichiatr.Soc. 17: 162-5 [PubMed]

Jenner JA, Stant AD, Offenbeek MAG, Vergert ten EM, Wiersma D. (2008). Implementatie van de nieuwe kosteneffectieve behandeling HIT voor patiënten met therapieresistente gehoorshallucinaties. Een beschrijvend onderzoek naar factoren die van invloed zijn op de implementatie van nieuwe behandelmethoden in de geestelijke gezondheidszorg. Eindrapportage aan de commissie doelmatigheid van ZON MW te Den Haag. In: Anonymous Groningen: UMCG, Universitair Centrum Psychiatrie

Ketelaars C, Horwitz E, Sytema S, Bos J, Wiersma D, Minderaa R, Hartman CA. (2008). Brief report: adults with mild autism spectrum disorders (ASD): scores on the autism spectrum quotient (AQ) and comorbid psychopathology. J.Autism Dev.Disord. 38: 176-80 [PubMed]

Priebe S, Frottier P, Gaddini A, Kilian R, Lauber C, Martinez-Leal R, Munk-Jorgensen P, Walsh D, Wiersma D, Wright D. (2008). Mental health care institutions in nine European countries, 2002 to 2006. Psychiatr.Serv. 59: 570-3 [PubMed]

Slooff CJ, Sijtzema H, Touw KP, Schilthuis M, Withaar F, Oven van W, Wiersma D. (2008). Diseasemanagement bij patiënten met psychotische stoornissen. MGv. 63: 7-19

Slooff CJ, Sijtzema HM, Touw KP, Schilthuis M, Withaar F, Oven van W, Wiersma D. (2008). Disease Management bij patiënten met psychotische stoornissen; Implementatie en herkenning van risicogroepen. In: Slooff CJ, Withaar F, Gaag van der M (eds). Complicaties bij de behandeling van mensen met een psychose. Den Haag: Schizofreniestichting: Kenniscentrum voor zorg en beleid

Slooff CJ, Withaar F, Touw KP, Velthuis M, Wiersma D. (2008). Disease Management voor schizofrenie patienten: verpleegkundige taken voor het voetlicht. In: Slooff CJ, Withaar F, Gaag van der M (eds). Complicaties bij de behandeling van mensen met een psychose. Den Haag: Schizofreniestichting: Kenniscentrum voor zorg en beleid

Stant AD, Vergert ten EM, Boer den PCAM, Wiersma D. (2008). Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders. Acta Psychiatr.Scand. 117: 57-66 [PubMed]

Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, GROUP Investigators: ( Kahn RS, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germys I), Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, St.Clair D, Stefansson K. (2008). Large recurrent microdeletions associated with schizophrenia. Nature. 455: 232-6 [PubMed]

Vrijenhoek T, Buizer-Voskamp JE, Stelt van der I, Strengman E, Genetic Risk and Outcome in Psychosis (GROUP) Consortium (, Kahn,R,S, Linszen DH, Os van J, Wiersma D, Bruggeman R, Cahn W, Haan de L, Krabbendam L, Myin-Germeys I), Sabatti C, Geurts van KA, Brunner HG, Ophoff RA, Veltman JA. (2008). Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am.J.Hum.Genet. 83: 504-10 [PubMed]

Wiersma D. (2008). Rehabilitation: new term for or further development of social psychiatry? A Dutch perspective. Int.Rev.Psychiatry. 20: 540-5 [PubMed]

Wiersma D. (2008). Concurreren in de GGZ: Welke praktische gevolgen heeft concurrentie voor de zorg bij psychosen en andere ernstige psychiatrische stoornissen? In: Keeman JN, Leeuw de PW, Mazel JA, Zitman FG (eds). Jaarboek Huisartsgeneeskunde 2008. Houten: Bohn Stafleu van Loghum

Wiersma D, Pijl YJ. (2008). Langverblijvers in de psychiatrie. Een epidemiologische beschouwing over hun omvang en samenstelling. Tijdschr Rehabil. 2: 12

Wunderink A, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering H, Wiersma D. (2008). Guided Discontinuation versus Maintenance Treatment in First Episode Psychosis: Relapse Rates and Functional Outcome, Schizophrenia Research. Schizophr.Res. 102: 52-3

Wunderink A, Sytema S, Nienhuis FJ, Wiersma D. (2008). Recovery and its Relation to Symptomatic and Functional Remission in First Episode Psychosis. Schizophr.Res. 102: 216

Boer den PCAM, Wiersma D, Vaarwerk ten I, Span MM, Stant AD, Bosch van den RJ. (2007). Cognitive self-therapy for chronic depression and anxiety: a multi-centre randomized controlled study. Psychol.Med. 37: 329-39 [PubMed]

Burns T, Catty J, Becker T, Drake RE, Fioritti A, Knapp M, Lauber C, Rossler W, Tomov T, Busschbach van JT, White S, Wiersma D, EQOLISE Group. (2007). The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial. Lancet. 370: 1146-52 [PubMed]

Heer de-Wunderink C, Caro-Nienhuis AD, Sytema S, Wiersma D. (2007). UTOPIA. Uit en Thuis: Onderzoek naar de Participerende Instellingen van de RIBW Alliantie. Groningen: Rob Giel Onderzoekcentrum. Verschenen als deel 16 in de RGOc-reeks

Holthausen EA, Wiersma D, Cahn W, Kahn RS, Dingemans PM, Schene AH, Bosch van den RJ. (2007). Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res. 149: 71-80 [PubMed]

Knegtering H, Bous J, Sytema S, Wiersma D. (2007). A randomized open-label comparison of the impact of aripirazole versus risperidone on sexual functioning (RAS study). Report made by the research team of The University Medical Centre of Groningen for Brystol-Meyers Squibb. In: Anonymous

Knegtering H, Bruggeman R, Castelein S, Wiersma D. (2007). Antipsychotica en seksueel functioneren bij mensen met psychosen [ntipsychotics and sexual functioning in persons with psychoses]. Tijdschr Psychiatr. 49: 733-42 [PubMed]

Priebe S, Mccabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, Rossler W, Salize H, Svensson B, Torres-Gonzales F, Brink van den RHS, Wiersma D, Wright DJ. (2007). Structured patient clinician communication and 1-year outcome in community mental healthcare: Cluster randomised controlled trial. Br.J.Psychiatry. 191: 420-6 [PubMed]

Stant AD, Buskens E, Jenner JA, Wiersma D, Vergert ten EM. (2007). Cost-effectiveness analysis in severe mental illness: outcome measures selection. J.Ment.Health Policy Econ. 10: 101-8 [PubMed]

Stant AD, Vergert ten EM, Boer den PCAM, Wiersma D. (2007). Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders. Acta Psychiatr.Scand. 117: 57-66 [PubMed]

Stant AD, Vergert ten EM, Wunderink L, Nienhuis FJ, Wiersma D. (2007). Economic consequences of alternative medication strategies in first episode non-affective psychosis. Eur.Psychiatry. 22: 347-53 [PubMed]

Sytema S, Wunderink A, Bloemers W, Roorda L, Wiersma D. (2007). Assertive Community Treatment in Nederland: een gerandomiseerde gecontroleerde trial. In: Slooff CJ, Withaar F, Gaag van der M (eds). Intensieve behandeling en begeleiding van mensen met een psychose. Den Haag: Schizofreniestichting

Sytema S, Wunderink L, Bloemers W, Roorda L, Wiersma D. (2007). Assertive community treatment in the Netherlands: a randomized controlled trial. Acta Psychiatr.Scand. 116: 105-12 [PubMed]

Wiersma D, Nienhuis FJ, Slooff CJ, Giel R, Jong de A. (2007). Reduction an assessment of psychiatric disability (RAPyD): Groningen, The Netherlands. In: Hopper K, Harrison G, Janca A, Sartorius N (eds). Recovery from schizophrenia, an international perspective. A report from the WHO Collaborative Project, The International Study of Schizophrenia. Oxford: University Press

Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D. (2007). Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J.Clin.Psychiatry. 68: 654-61 [PubMed]

Wunderink L, Nienhuis FJ, Sytema S, Wiersma D. (2007). Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr.Bull. 33: 792-6 [PubMed]

Boonstra TC, Wunderink A, Wit de P, Noorthoorn E, Wiersma D. (2006). Incidence and gender distribution of non-affective psychotic disorders in the Netherlands. Schizophr.Res. 86: s64

Boonstra TC, Wunderink A, Wit de P, Noorthoorn EO, Wiersma D. (2006). The administrative incidence of psychosis in The Netherlands. Schizophr.Res. 81: 229

Burns T, Becker T, Catty J, Fioritti A, Knapp M, Lauber C, Rössler W, Tomov T, Busschbach van JT, White S, Wiersma D, and the EQOLISE Group. (2006). Enhancing the Quality of Life and Independence of persons disabled by severe mental illness through supported employment. The EQOLISE study. Final Report to European Commission QLRT-2001-00683. London: St. Georges

Busschbach van JT, Visser E, Sytema S, Wiersma D. (2006). Blijvend aan het werk. Onderzoek naar het lange termijn resultaat van arbeidsrehabilitatie bij DAAT-Drenthe. Groningen: Rob Giel Onderzoekcentrum/UMCG. Verschenen als deel 9 in de RGOc-reeks

Castelein S, Bruggeman R, Busschbach van JT, Gaag van der M, Knegtering R, Wiersma D. (2006). The effectiveness of ‘professionally guided’ self-help groups: A multicenter randomized controlled trial. Schizophr.Res. 86: s56

Castelein S, Bruggeman R, Busschbach van JT, Wiersma D. (2006). Begeleide lotgenotengroepen voor mensen met een psychose. Een gecontroleerde effectiviteitsstudie. Groningen: Rob Giel Onderzoekcentrum/UMCG. Verschenen als deel 10 in de RGOc-reeks

Gaag van der M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, Haan de L, Meijel van B, Harten van PN, Valmaggia L, Hert de M, Wiersma D. (2006). The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published 5-factor solutions. Schizophr.Res. 85: 273-9 [PubMed]

Gaag van der M, Hoffman T, Remijsen M, Hijman R, Haan de L, Meijel van B, Harten van PN, Valmaggia L, Hert de M, Cuijpers A, Wiersma D. (2006). The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model. Schizophr.Res. 85: 280-7 [PubMed]

Hoeken van D, Gaag van der M, Wiersma D, Hoek HW. (2006). Alcohol abuse and low acculturation: an unhappy marriage for the functioning of patients with schizophrenia. Schizophr.Res. 81: 298

Jenner JA, Nienhuis FJ, Willige van de G, Wiersma D. (2006). “Hitting” Voices of Schizophrenia Patients May Lastingly Reduce Persistent Auditory Hallucinations and Their Burden: 18-month Outcome of a Randomized Controlled Trial. Can.J.Psychiatry. 51: 169-78 [PubMed]

Jenner JA, Wiersma D. (2006). L’ efficacia degli interventi psicosociali per le allucinazioni uditive verbali. Riv Sper Freniatr. 130: 111-41

Jenner JA, Willige van de G, Wiersma D. (2006). Multi-family treatment for patients with persistent auditory hallucinations and their relatives: a pilot study. Acta Psychiatr.Scand. 113: 154-8 [PubMed]

Jenner JA, Willige van de G, Wiersma D. (2006). Kinderen en adolescenten met hallucinaties. Gehoorshallucinaties bij zeven- en achtjarige leerlingen van de basisschool: prevalentie, kenmerken en relatie met gedragsproblemen. In: Jenner JA (ed). Hallucinaties: kenmerken, verklaringen en behandeling. Assen: Van Gorcum

Knegtering H, Boks M, Blijd C, Castelein S, Bosch van den RJ, Wiersma D. (2006). A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J.Sex Marital Ther. 32: 315-26 [PubMed]

Kovess-Masfety V, Wiersma D, Xavier M, Caldas de Almeida JM, Carta MG, Dubuis J, Lacalmontie E, Pellet J, Roelandt JL, Torres-Gonzalez F, Moreno Kustner B, Walsh D. (2006). Needs for care among patients with schizophrenia in six European countries: a one-year follow-up study. Clin Pract Epidemol Ment Health. 2: 22 [PubMed]

Wiersma D. (2006). Needs of people with severe mental illness. Acta Psychiatr.Scand.: 115-9 [PubMed]

Wiersma D. (2006). Historie opnamevervanging en onderzoek: is het einde van de extramuralisering al in zicht? In: Snijdewind A (ed). Bedloze Psychiatrie. Badhoevedorp: Mension

Wiersma D. (2006). Role Functioning as a component of Quality of Life in Mental Disorders. In: Katschnig H, Freeman H, Sartorius N (eds). Quality of Life in Mental Disorders. Chichester: Wiley

Wolters HA, Knegtering R, Wiersma D, Bosch van den RJ. (2006). Evaluation of the subjects’ response to antipsychotics questionnaire. Int.Clin.Psychopharmacol. 21: 63-9 [PubMed]

Wunderink A, Nienhuis FJ, Sytema S, Wiersma D. (2006). Treatment delay and response rate in first episode psychosis. Acta Psychiatr.Scand. 113: 332-9 [PubMed]

Boer den PCAM, Wiersma D, Russo S, Bosch van den RJ. (2005). Paraprofessionals for anxiety and depressive disorders. Cochrane Database Syst.Rev. Issue 2. Art. No.: CD004688

Boer den PCAM, Wiersma D, Vaarwerk ten I, Stant AD, Bosch van den RJ. (2005). Cognitieve Zelftherapie voor patiënten met chronisch-recidiverende depressie of (gegeneraliseerde) angststoornis. Groningen: Rob Giel Onderzoekcentrum. Verschenen als deel 8 in de RGOc-reeks

Brink van den RHS, Os van TWDP, Wiersma D. (2005). Inventarisatie zorgprogrammering Forensisch Psychiatrisch Circuit Hofressort Leeuwarden. Eindrapport. Groningen: Rob Giel Onderzoekcentrum, Psychiatrie, Universitair Medisch Centrum Groningen

Busschbach van JT, Wiersma D. (2005). De cliënt is koning. Een onderzoek naar de ervaringen met de IRB op basis van interviews met 35 cliënten van de Centra voor Individuele Rehabilitatie en Educatie (CIRE) in Groningen. In: Droës J (ed). Individuele rehabilitatie en herstel van mensen met psychiatrische problemen. Amsterdam: SWP

Castelein S, Bruggeman R, Busschbach van JT, Gaag van der M, Mulder PJ, Knegtering H, Wiersma D. (2005). The effectiveness of support groups for people suffering from psychosis: A multi-center randomized controlled trial. Schizophr.Bull. 31: s521-2

Horwitz EH, Sytema S, Ketelaars CEJ, Wiersma D. (2005). Twee zelfrapportagescreeningsvragenlijsten voor autismespectrumstoornissen bij volwassenen. Een valideringsonderzoek. Tijdschr Psychiatr. 47: 291-8

Kovess-Masfety V, Caldas de Almeida JM, Carta MG, Dubuis J, Lacalmontie E, Pellet J, Roelandt JL, Moreno Kustner B, Walsh D, Wiersma D. (2005). Professional team’s choices of intervention towards problems and needs of patients suffering from schizophrenia across six European countries. Eur.Psychiatry. 20: 521-8 [PubMed]

Priebe S, Badesconyi A, Fioritti A, Hansson L, Kilian R, Torres-Gonzales F, Turner T, Wiersma D. (2005). Reinstitutionalisation in mental health care: comparison of data on service provision from six European countries. Br.Med.J. 330: 123-6 [PubMed]

Wiersma D, Sytema S. (2005). ‘Routine Outcome Assessment (ROA) and Management’ in de Geestelijke Gezondheidszorg. In: Schene AH, Boer F, Heeren TJ, Jaspers JPC, Sabbe B, Weeghel van J (eds). Jaarboek Psychiatrie en Psychotherapie. Houten: Bohn Stafleu van Loghum

Willige van de G, Wiersma D, Nienhuis FJ, Jenner JA. (2005). Changes in quality of life in chronic psychiatric patients: a comparison between EuroQol (EQ-5D) and WHOQoL. Qual.Life Res. 14: 441-51 [PubMed]

Wolters HA, Knegtering H, Wiersma D, Bosch van den RJ. (2005). Quality of life and patients’ evaluation of antipsychotic medication. Schizophr.Bull. 31: 573-4

Boer den PCAM, Mersch PPA, Wiersma D. (2004). Cognitieve zelftherapie. Verslag van een pilot-studie naar een alternatieve behandeling voor psychiatrische patiënten. MGv. 59: 325-38

Boer den PCAM, Wiersma D, Bosch van den RJ. (2004). Paraprofessionals for anxiety and depressive disorders (Protocol for a Cochrane Review). The Cochrane Library Issue 1. Cochrane Database Syst Rev. 1

Boer den PCAM, Wiersma D, Bosch van den RJ. (2004). Why is self-help neglected in the treatment of emotional disorders? A meta-analysis. Psychol.Med. 34: 959-71 [PubMed]

Boer den PCAM, Wiersma D, Vaarwerk ten I, Stant AD. (2004). Cognitieve Zelftherapie voor patiënten met chronisch-recidiverende depressie en angststoornis. Eindverslag OG00-028. Groningen: Universitair Medisch Centrum Groningen

Brink van den RHS, Wiersma D. (2004). Front Office: Functioneren 7 x 24 uurs crisisinterventie Openbare Geestelijke Gezondheidszorg op het politiebureau. Groningen: Rob Giel Onderzoekcentrum, Psychiatrie, Universitair Medisch Centrum Groningen

Havenaar JM, Os van J, Wiersma D. (2004). Het gebruik van algemene meetinstrumenten in de psychiatrische praktijk. Tijdschr Psychiatr. 46: 647-51

Jenner JA, Nienhuis FJ, Wiersma D, Willige van de G. (2004). HIT, Hallucination focused Integrative Treatment: a randomized controlled trial. Schizophr.Bull. 30: 133-45 [PubMed]

Jenner JA, Willige van de G, Nienhuis FJ, Wiersma D. (2004). HIT. Een integrerende symptoomgerichte behandeling voor patiënten met therapieresistente gehoorshallucinaties. Gedragstherapie. 37: 5-24

Jenner JA, Willige van de G, Nienhuis FJ, Wiersma D. (2004). Hallucination focused integrative treatment induces statistically significant subjective and objective improvements in chronic schizophrenia patients with persistent voices. Schizophr.Res. 67: s145-6

Jenner JA, Willige van de G, Wiersma D. (2004). Effectiveness of multi-family training aftercare for therapy refractory voice hearers: a pilot-study. Schizophr.Res. 67: s146

Lammeren van AMDN, Ketelaars CEJ, Horwitz EH, Wiersma D. (2004). ADHD en ASS bij volwassenen. Onderzoek naar diagnostiek van ADHD en ASS bij normaal begaafde volwassenen, alsmede naar de functionele beperkingen en zorgbehoeften. Groningen: Polikliniek Psychiatrie Academisch Ziekenhuis Groningen (AZG) i.s.m. Rob Giel Onderzoekcentrum (RGOc). Verschenen als deel 6 in de RGOc-reeks

Wiersma D. (2004). Evidentie voor de Geestelijke Gezondheidszorg. De klinische epidemiologie van psychiatrische stoornissen. Oratie. Groningen: Rob Giel Onderzoekcentrum. Verschenen als deel 5 in de RGOc-reeks

Wiersma D, Jenner JA, Nienhuis FJ, Stant AD, Willige van de G. (2004). Improvement of quality of life of schizophrenia patients with persistent auditory hallucinations by means of integrated treatment: is it cost-effective? Acta Psychiatr.Scand. 110: s58

Wiersma D, Jenner JA, Willige van de G, Nienhuis FJ. (2004). Hallucinations focused Integrative Treatment improves Quality of life in schizophrenia patients. Acta Psychiatr.Scand. 109: 194-201 [PubMed]

Wiersma D, Willige van de G, Nienhuis FJ, Jenner JA. (2004). Changes in quality of life in schizophrenic patients: a comparison between Euroqol and WHO-QoL. Schizophr.Res. 67: s232 [PubMed]

Wolters HA, Knegtering H, Wiersma D, Bosch van den RJ. (2004). A valid and reliable instrument for measuring the subjective response to antipsychotic medication. Schizophr.Res. 67: s193

Castelein S, Jansen G, Wiersma D. (2003). Zorg voor mensen met schizofrenie. In: Landelijk Expertisecentrum Verpleging en Verzorging Utrecht (ed). State-of-the-Art Studie Verpleging en Verzorging. Maarssen: Elsevier Gezondheidszorg

Doeglas D, Bosch van den RJ, Trompenaars F, Wiersma D. (2003). De PBL: een korte vragenlijst voor het meten van psychische beperkingen. TSG. 81: 34-43

Haren van NE, Cahn W, Hulshoff Pol HE, Schnack HG, Caspers E, Lemstra A, Sitskoorn MM, Wiersma D, Bosch van den RJ, Dingemans PM, Schene AH, Kahn RS. (2003). Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study. Schizophr.Res. 64: 41-52 [PubMed]

Holthausen EAE, Wiersma D, Sitskoorn MM, Dingemans PM, Schene AH, Bosch van den RJ. (2003). Long-term memory deficits in schizophrenia: primary or secondary dysfunction? Neuropsychology. 17: 539-47 [PubMed]

Jenner JA, Willige van de G, Nienhuis FJ, Wiersma D. (2003). Het belang van een geïntegreerde behandeling voor mensen met gehoorshallucinaties: Het HITprogramma. MGv. 58: 1124-36

Marshall M, Crowther R, Maraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D. (2003). Day hospital versus admission for acute psychiatric disorders. Cochrane Database Syst.Rev.: CD004026 [PubMed]

Pijl YJ, Haar van der ES, Wiersma D, Sytema S. (2003). Extramuralisering en deconcentratie van de Drentse GGZ. MGv. 58: 574-86

Stant AD, Vergert ten EM, Groen H, Jenner JA, Nienhuis FJ, Willige van de G, Wiersma D. (2003). Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations. Acta Psychiatr.Scand. 107: 361-8 [PubMed]

Willige van de G, Jenner JA, Wiersma D. (2003). Blijvende stemmen de baas. Multi Family Treatment (MFT) een geïntegreerde vorm van nabehandeling voor patiënten met persisterende auditieve hallucinaties en sociale beperkingen. Groningen: AZG, afd. Psychiatrie/Kenniscentrum Schizofrenie i.s.m. Rob Giel Onderzoekcentrum. Verschenen als deel 4 in de RGOc-reeks

Wolters HA, Knegtering H, Wiersma D, Bosch van den RJ. (2003). The spectrum of subjective effects of antipsychotic medication. Acta Neuropsychiatrica. 15: 279 [ Download vragenlijst]

Wolters HA, Knegtering H, Wiersma D, Bosch van den RJ. (2003). Experiences of patients with antipsychotic medication: a questionnaire. Schizophr.Res. 60 (Abstracts of the IXth International Congress on Schizophrenia Research): 370

Busschbach van JT, Wiersma D. (2002). Does rehabilitation meet the needs of care and improve the quality of life of patients with schizophrenia or other chronic mental disorders? Community Ment.Health J. 38: 61-70 [PubMed]

Pijl YJ, Sytema S, Barels R, Wiersma D. (2002). Costs of deinstitutionalization in a rural catchment area in The Netherlands. Psychol.Med. 32: 1435-43 [PubMed]

Priebe S, Mccabe R, Bullenkamp J, Hansson L, Rossler W, Torres-Gonzales F, Wiersma D. (2002). The impact of routine outcome measurement on treatment processes in community mental health care: approach and methods of the MECCA study. Epidemiol.Psichiatr.Soc. 11: 198-205 [PubMed]

Wiersma D. (2002). [Care requirements for chronic psychiatric patients in general practice: shared responsibility with mental health professionals]. Ned.Tijdschr.Geneeskd. 146: 701-3 [PubMed]

Wiersma D, Kluiter H, Pijl YJ, Sytema S. (2002). Mental Health Care in the Netherlands. Community Care with or without Hospitals. Int J Ment Health. 31: 50-65

Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, An Der Heiden W, Holmberg SK, Janca A, Lee PW, Leon CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D. (2001). Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br.J.Psychiatry. 178: 506-17 [PubMed]

Ormel J, Neeleman J, Wiersma D. (2001). Determinanten van psychische ongezondheid: implicaties voor onderzoek en beleid. Tijdschr Psychiatr. 4: 245-58

Pijl YJ, Kluiter H, Wiersma D. (2001). Deinstitutionalisation in the Netherlands. Eur.Arch.Psychiatry Clin.Neurosci. 251: 124-9 [PubMed]

Wiersma D, Busschbach van JT. (2001). Are needs and satisfaction of care associated with quality of life? An epidemiological survey among the severely mentally ill in the Netherlands. Eur.Arch.Psychiatry Clin.Neurosci. 251: 239-46 [PubMed]

Wiersma D, Jenner JA, Nienhuis FJ, Stant AD, Willige van de G. (2001). Last van stemmen. Een gecontroleerde (kosten)effectiviteitsstudie naar een op Hallucinaties gerichte Integratieve Therapie (HIT) bij patiënten met schizofrenie of verwante psychose. Groningen: Rob Giel Onderzoekcentrum. Verschenen als deel 3 in de RGOc-reeks

Wiersma D, Jenner JA, Willige van de G, Spakman M, Nienhuis FJ. (2001). Cognitive behaviour therapy with coping training for persistent auditory hallucinations in schizophrenia: a naturalistic follow-up study of the durability of effects. Acta Psychiatr.Scand. 103: 393-9

Appelo MT, Tak C, Bosch van den RJ, Wiersma D. (2000). Zelfcontrole training bij patiënten met een psychotische stoornis: een gecontroleerde studie. Dth. 20: 105-18

Carpiniello B, Carta MG, Wiersma D, Kovess-Masfety V, Caria A, Caldas de Almeida JM, Dubuis J, Lacalmontie E, Moreno Kustner B, Peller J, Porcedda R, Roelandt JL, Salize HJ, Torres-Gonzalez F, Walsh D. (2000). Needs for care of schizophrenic patients. Preliminary results from a European research project. Minerva Psichiatr. 41: 67-75

Kooi L, Sytema S, Wiersma D, Driessen G, Wierdsma AI, Dieperink CJ. (2000). GGz onder druk? Verkenning van de toenemende druk op GGz-voorzieningen met behulp van drie Nederlandse Psychiatrische Casusregisters. MGv. 3: 223-30

Pijl YJ, Kluiter H, Wiersma D. (2000). Increasing use of Dutch mental health care: an investigation. Soc.Psychiatry Psychiatr.Epidemiol. 35: 564-8 [PubMed]

Pijl YJ, Kluiter H, Wiersma D. (2000). Change in Dutch mental health care: an evaluation. Soc.Psychiatry Psychiatr.Epidemiol. 35: 402-7 [PubMed]

Selten JP, Wiersma D, Bosch van den RJ. (2000). Distress attributed to negative symptoms in schizophrenia. Schizophr.Bull. 26: 737-44 [PubMed]

Selten JP, Wiersma D, Bosch van den RJ. (2000). Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms. Compr.Psychiatry. 41: 191-6 [PubMed]

Selten JP, Wiersma D, Bosch van den RJ. (2000). Discrepancy between subjective and objective ratings for negative symptoms. J.Psychiatr.Res. 34: 11-3 [PubMed]

Tak C, Appelo MT, Bosch van den RJ, Wiersma D. (2000). Dertig jaar psychosociale interventies bij schizofrenie. Tijdschr Psychiatr. 42: 95-110

Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, An Der Heiden W, Nienhuis FJ, Walsh D. (2000). Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol.Med. 30: 1155-67 [PubMed]

Selten JP, Gernaat HB, Nolen WA, Wiersma D, Bosch van den RJ. (1998). Experience of negative symptoms: comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects. Am.J.Psychiatry. 155: 350-4 [PubMed]

Wiersma D, Sytema S, Busschbach van JT, Schreurs M, Kroon H, Driessen G. (1997). Prevalence of long-term mental health care utilization in The Netherlands. Acta Psychiatr.Scand. 96: 247-53 [PubMed]